NCT03268161View on ClinicalTrials.gov

Prevalence of Genetic Mutations in Patients With Neuropathy Associated With Anti-Myelin-associated Glycoprotein (MAG) Antibodies

CompletedOBSERVATIONAL
Enrollment

26

Participants

Timeline

Start Date

October 21, 2015

Primary Completion Date

November 10, 2017

Study Completion Date

November 10, 2017

Conditions
Neuropathy Demyelinating
Interventions
DIAGNOSTIC_TEST

Mutational analysis of clonal B cells

"Mutational analysis based on medullary or blood samples stored in a bio-bank during routine lymphocyte phenotyping.~Mutations affecting MYD88 (MYD88 L265P mutation), CXCR4 (Whim-like CXCR4 mutation) loci are sought."

Trial Locations (1)

35000

Rennes University Hospital, Rennes

All Listed Sponsors
lead

Rennes University Hospital

OTHER

NCT03268161 - Prevalence of Genetic Mutations in Patients With Neuropathy Associated With Anti-Myelin-associated Glycoprotein (MAG) Antibodies | Biotech Hunter | Biotech Hunter